China Pharma Holdings Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of China Pharma Holdings Inc (CPHI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: China Pharma Holdings Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 4M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-3.1% annualized vs trailing 12 months).
- Scale: China Pharma Holdings Inc ranks #363 of 544 companies by market capitalization in the Major Pharmaceutical Preparations industry, holding 0.0% of industry market cap.
- Peer revenue share: China Pharma Holdings Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CPHI Sales vs. its Competitors, Q2 2026
China Pharma Holdings Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Major Pharmaceutical Preparations industry grew revenue 9.0% year over year, combined, vs -7.6% for China Pharma Holdings Inc. China Pharma Holdings Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
China Pharma Holdings Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| China Pharma Holdings Inc | No | No | No | Yes |
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 8) | 50.00 % (4 of 8) | 25.00 % (2 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CPHI Stock Performance relative to its Competitors
CPHI Stock Performance relative to Similar-Size Competitors
CPHI Stock Performance relative to Similar Growth & Profitability Competitors
China Pharma Holdings Inc's Comment on Competition and Industry Peers
China Pharma Holdings Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Helpson | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for China Pharma Holdings Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.